Is Unituxin used for neuroblastoma?

Is Unituxin (dinutuximab) used to treat neuroblastoma?

Yes. Unituxin (dinutuximab) is used for neuroblastoma, specifically for high-risk neuroblastoma in children, typically as part of combination therapy after intensive treatment such as induction chemotherapy, surgical resection, and stem cell transplant. [1]

What stage/type of neuroblastoma is Unituxin for?

Unituxin is indicated for high-risk neuroblastoma, most often in the post-consolidation setting (after stem cell transplant) and used with other therapies as part of a multi-agent treatment plan. [1]

How does it fit with other neuroblastoma treatments?

Unituxin is an immunotherapy (dinutuximab) used alongside other standard components of high-risk neuroblastoma care rather than as a standalone treatment. Its use is tied to established combination protocols in that high-risk population. [1]

Who typically receives it?

It is used in pediatric high-risk neuroblastoma patients as part of the overall treatment sequence. [1]

Where can I verify the official indication?

You can check Unituxin’s labeled use and neuroblastoma indication details via DrugPatentWatch.com. [1]

Sources:
[1] DrugPatentWatch.com – Unituxin (dinutuximab) indication and related information